Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Harmony Gold Mining Co. (HMY) vs Mesoblast Limited (MESO) Price & Performance

Harmony Gold Mining Co.Trade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

Harmony Gold Mining Co. vs Mesoblast Limited — how do they compare? Harmony Gold Mining Co. trades at $15.08 (market cap $9.07B), while Mesoblast Limited trades at $16.28 (market cap $2.17B). The key difference: Harmony Gold Mining Co. is far larger — about 4.2× Mesoblast Limited's market cap, and Harmony Gold Mining Co. pays a 2.84% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.

HMYMESO
Market Cap
$9.07B$2.17B
Sector
Basic MaterialsTechnology
52-Week High
$26.04$20.96
52-Week Low
$12.61$12.88
Enterprise Value
$9.41B$2.17B
Dividend Yield
2.84%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Harmony Gold Mining Co.

Harmony Gold Mining (HMY) trades at $14.37, down 1.91% on the day, amid a bearish technical signal and mixed sentiment. The company shows strong fundamentals with a P/E of 9.37, net income margin of 20.06%, and robust cash flow from operations of $15.65 billion in 2024. Recent earnings beat expectations in Q2 2025 but missed in Q4 2025, while revenue grew to $61.38 billion in 2024. A dividend of $0.31 is scheduled for payment in May 2026, adding income appeal.

Outlook is cautious due to technical weakness and analyst skepticism (70% hold rating), but valuation metrics and profitability support potential upside if gold prices stabilize. Key risks include Fed rate sensitivity and operational execution amid the transition to a gold-copper hybrid model. The stock presents a value opportunity with manageable debt, though near-term volatility may persist.

Mesoblast Limited

MESO trades at $16.63, down 3.98% on the day, with a bullish technical outlook supported by moving averages. The company shows strong revenue growth with Ryoncil generating $115 million in annual revenue, though it remains unprofitable with a net loss of $102 million. Recent developments include positive Phase 3 trial progress and FDA BLA filings for new treatments.

Investment outlook balances promising pipeline progress against significant financial losses. The stock offers growth potential through commercial expansion but carries substantial risk from continued cash burn and regulatory hurdles. Analyst consensus leans bullish with 45% buy ratings, reflecting optimism about the company's transition to commercial-stage operations.

Returns comparison

Trailing returns across standard periods

About Harmony Gold Mining Co.

Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.

Read more on HMY

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO